Quantitative Investment Management LLC Purchases Shares of 40,354 Bath & Body Works, Inc. $BBWI

Quantitative Investment Management LLC purchased a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 40,354 shares of the company’s stock, valued at approximately $933,000.

A number of other hedge funds also recently made changes to their positions in the stock. Chase Investment Counsel Corp acquired a new position in shares of Bath & Body Works in the 4th quarter worth approximately $1,606,000. Bank of America Corp DE boosted its stake in shares of Bath & Body Works by 26.2% in the 1st quarter. Bank of America Corp DE now owns 2,050,414 shares of the company’s stock valued at $38,281,000 after purchasing an additional 425,248 shares during the last quarter. BlackRock Inc. acquired a new stake in shares of Bath & Body Works during the second quarter worth $449,065,000. Intech Investment Management LLC increased its position in shares of Bath & Body Works by 462.6% during the fourth quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock worth $2,184,000 after buying an additional 89,432 shares during the period. Finally, Cibc World Market Inc. bought a new position in Bath & Body Works during the fourth quarter worth $2,053,000. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Trading Down 3.3%

Bath & Body Works stock opened at $18.62 on Wednesday. The firm has a market capitalization of $3.75 billion, a price-to-earnings ratio of 4.85, a price-to-earnings-growth ratio of 2.00 and a beta of 1.38. The firm’s fifty day moving average price is $20.25 and its two-hundred day moving average price is $19.90. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $32.32.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The company’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.30 EPS. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, research analysts forecast that Bath & Body Works, Inc. will post 2.7 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s payout ratio is 20.83%.

Analyst Ratings Changes

BBWI has been the subject of a number of recent analyst reports. Robert W. Baird decreased their price target on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a report on Thursday, August 27th. Deutsche Bank Aktiengesellschaft set a $22.00 price objective on Bath & Body Works in a research note on Thursday, August 27th. Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They set a “neutral” rating and a $20.00 target price on the stock. Wells Fargo & Company decreased their target price on Bath & Body Works from $26.00 to $24.00 and set an “overweight” rating for the company in a research note on Thursday, August 27th. Finally, The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $23.00 to $19.00 in a report on Wednesday, July 8th. Four investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and a consensus target price of $22.29.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.